NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
1.780
+0.020 (1.14%)
Aug 21, 2026, 9:50 AM EDT - Market open
NervGen Pharma Employees
NervGen Pharma had 10 employees as of December 31, 2025. The number of employees increased by 3 or 42.86% compared to the previous year.
Employees
10
Change
3
Growth
42.86%
Revenue / Employee
n/a
Profits / Employee
-$4,362,912
Market Cap
191.39M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 10 | 3 | 42.86% | 9 | 1 |
| Dec 31, 2019 | 7 | - | - | 7 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| Innate Pharma | 164 |
| MediWound | 121 |
| Nkarta | 106 |
| Caribou Biosciences | 97 |
| Alpha Cognition | 71 |
| Armata Pharmaceuticals | 61 |
| Acumen Pharmaceuticals | 61 |
NGEN News
- 4 days ago - NervGen Pharma reports Q2 EPS (C$0.37) vs. (C$0.13) last year - TheFly
- 8 days ago - NervGen Pharma Earnings release: Q2 2026 - Filings
- 8 days ago - NervGen Reports Second Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire
- 5 weeks ago - NervGen Pharma price target lowered to $15 from $18 at H.C. Wainwright - TheFly
- 5 weeks ago - NervGen Pharma initiated with an Outperform at Leerink - TheFly
- 2 months ago - NervGen Pharma initiated with a Buy at TD Cowen - TheFly
- 3 months ago - NervGen Pharma files $250M mixed securities shelf - TheFly
- 3 months ago - NervGen Pharma Registration statement: Registration filing - Filings